Drug
Clobetasol clinical trials
Also written SVT-15473.
Keep track of what changes. Save the Clobetasol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
47 studies that test it; most in 2008 (5)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 20 · Other 27
Galderma R&D (6) · LEO Pharma (3) · Salvat (3) · Stiefel, a GSK Company (3) · Medstar Health Research Institute (2) · Actavis Inc. (2) · Assistance Publique - Hôpitaux de Paris (2) · Malmö University (1)
Often tested with
Tested in the same studies.
Betamethasone dipropionate (3) · Betamethasone (3) · Calcitriol (3) · Calcipotriene (3) · Pimecrolimus (2) · Halobetasol (2) · Triamcinolone Acetonide (2) · Triamcinolone (2)
Related medicines
As reviewed, each with the page that says it.
- One of Glucocorticoids source
Studies
Open first, then newest update. How each study uses Clobetasol is read from its arms, and is right about nine times in ten.
Testing it · 47
- Efficacy of Clobetasol Vs Intralesional Triamcinolone in Lichen Planus TreatmentNot yet recruitingPhase 4Noor AzizNCT07666620Written as Clobetasol propionate 0.05% cream
- Comparison of the Efficacy of Clobetasol Propionate 0.05% Mouthwash, Photobiomodulation, and Their Combination in Managing of Oral Lesions in Patient With Pemphigus Vulgaris.RecruitingNot applicableDamascus UniversityNCT07641725Written as Clobetasol propionate 0.05% Mouthwash
- Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen PlanusRecruitingPhase 2University of PalermoNCT07100613Written as Clobetasol Patch
- Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric PopulationRecruitingPhase 3SalvatNCT05724446Written as Clobetasol Propionate
- Topical Steroids Alone or Associated With Methotrexate in Bullous PemphigoidCompletedPhase 3University Hospital, MontpellierNCT02313870Written as clobetasol propionate + Methotrexate
- ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin ReactionCompletedNot applicableGazi UniversityNCT06856590Written as Clobetasol Propionate 0.05% Cream
- Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen SclerosusCompletedPhase 4Medstar Health Research InstituteNCT04951206Written as Clobetasol Propionate 0.05% Ointment
- A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy SkinCompletedPhase 1LEO PharmaNCT02355639Written as Clobetasol propionate 0.05 % ointment
- A Vasoconstriction Study With LEO 90100CompletedPhase 1LEO PharmaNCT01946386Written as Dermovate® cream
- A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedPhase 1LEO PharmaNCT02376049Written as Clobetasol propionate cream
- Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.Active, not recruitingPhase 2/3Malmö UniversityNCT04364555Written as Clobetasol Propionate
- Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in PsoriasisCompletedPhase 4Dermatology Consulting Services, PLLCNCT06042647Written as 0.05% Clobetasol Propionate
- Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)CompletedPhase 3SalvatNCT04249076Written as Clobetasol Propionate
- Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)CompletedPhase 3SalvatNCT04246801Written as Clobetasol propionate
- Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%CompletedPhase 4Galderma R&DNCT01893567Written as Clobex Spray
- Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the ScalpCompletedPhase 4Galderma R&DNCT00881868Written as clobetasol propionate spray 0.05%
- Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque PsoriasisCompletedPhase 3Galderma R&DNCT00658788Written as clobetasol propionate spray 0.05%
- Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque PsoriasisCompletedPhase 4Galderma R&DNCT00733954Written as clobetasol propionate spray
- Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in PsoriasisCompletedPhase 4Galderma R&DNCT00437255Written as Clobetasol Propionate, 0.05%
- A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) FoamCompletedPhase 4Galderma R&DNCT00436540Written as Clobetasol Propionate 0.05% Spray
See all 47 studies that test Clobetasol →
Given in every arm · 5 — Clobetasol is usual care beside what is tested
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)RecruitingPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT06504160Written as Clobetasol Ointment
- Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus LazertinibActive, not recruitingPhase 2Janssen Research & Development, LLCNCT06120140Written as Clobetasol
- Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal CancerCompletedPhase 2Academic and Community Cancer Research UnitedNCT02368886Written as Clobetasol Propionate
- Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the VulvaWithdrawnPhase 3Fundación Eduardo AnituaNCT05364515Written as Clobetasol Propionate
- A Study Assessing GW870086's Potential to Cause Skin ThinningCompletedPhase 1GlaxoSmithKlineNCT01381445Written as Clobetasol Propionate
As the comparator · 26 — what is tested is compared with Clobetasol
- Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?RecruitingPhase 2Centre Hospitalier Universitaire de NiceNCT06742333Written as Clobetasol
- Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy.Not yet recruitingNot applicableMilosz PietrusNCT07240389Written as Clobetasol Propionate 0.05% Cream (Dermovate)
- Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen SclerosusRecruitingNot applicableKantonsspital Winterthur KSWNCT06135402Written as Treatment with Clobetasol
- Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis PatientsRecruitingPhase 3Cairo UniversityNCT04649697Written as Clobetasol Propionate
- Impact of PDT and Topical Corticosteroids on Taste Perception and Salivary Oxidative Stress Markers in Patients With OLPCompletedNot applicableMedical University of BialystokNCT07536737Written as Clobetasol Propionate 0.05% Cream
- Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen SclerosusCompletedNot applicableProf. Dr. Volker ViereckNCT03926299Written as Clobetasol propionate 0.05% ointment
- Laser vs Clobetasol for Lichen SclerosusCompletedPhase 3Ruhr University of BochumNCT05010421Written as Clobetasol 0.05% Emollient Top Cream
- Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque PsoriasisCompletedPhase 2GEN İlaç ve Sağlık Ürünleri A.Ş.NCT05706870Written as Clobetasol 17-propionate
- A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy SkinCompletedPhase 1LEO PharmaNCT02392130Written as Clobetasol propionate 0.05% ointment
- A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled StudyCompletedPhase 2Wroclaw Medical UniversityNCT06752343Written as Clobetasol
- Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With PsoriasisCompletedEarly Phase 1Dr. Jose N. Rodriguez Memorial Hospital and SanitariumNCT06555497Written as clobetasol propionate 0.05% ointment
- Progesterone vs Clobetasol Propionate in Vulvar Lichen SclerosusTerminatedPhase 2Insel Gruppe AG, University Hospital BernNCT01126255Written as Clobetasol propionate 0.05%
- PRF in Management of Chronic Multiple Oral UlcersCompletedPhase 1Beni-Suef UniversityNCT03878771Written as Dermovate cream in Orabase
- Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma.CompletedPhase 2Instituto de Investigacion Sanitaria La FeNCT03961126Written as Corticosteroids (clobetasol 0.05%)
- Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen PlanusCompletedPhase 2University of Sao PauloNCT03386643Written as Clobetasol propionate 0.05%
- Evaluation of the Vasoconstriction Properties of MC2-01 CreamCompletedPhase 1MC2 TherapeuticsNCT03758365Written as Clobetasol Propionate 0.05% Lotion
- A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous PemphigoidTerminatedPhase 2TWi Biotechnology, Inc.NCT03286582Written as Clobetasol 0.05% Topical Ointment
- Photobiomodulation in Oral Lichen PlanusStatus unknownNot applicableUniversity of Nove de JulhoNCT03320460Written as Propionate clobetasol gel 0.05%
- DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque PsoriasisCompletedPhase 2Promius Pharma, LLCNCT02131324Written as Clobetasol Propionate Cream 0.05%
- Topical Betamethasone and Clobetasol in Orabase in Oral Lichen PlanusStatus unknownPhase 2Garlapati KomaliNCT03026478Written as Clobetasol Propionate
Showing 20 of 26.
Codes
What other systems call Clobetasol · ClinicalTrials.gg INT007229
- MeSH (NLM) D002990ClobetasolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) ADN79D536HCLOBETASOLConfirmed FDA, NLM, Wikidata
- RxNorm 2590Confirmed FDA, Wikidata
- Wikidata Q4224007clobetasolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65339ClobetasolOne source FDA
- DrugBank DB11750One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002990 | Clobetasol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | ADN79D536H | CLOBETASOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2590 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4224007 | clobetasol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65339 | Clobetasol | One source FDA |
| DrugBank | DB11750 | — | One source Wikidata |
Also registered as clobetasol propionate (UNII 779619577M · RxNorm 21245).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.